Adjuvant radiotherapy for gastric cancer: A dosimetric comparison of 3-dimensional conformal radiotherapy, tomotherapy® and conventional intensity modulated radiotherapy treatment plans

Medical Dosimetry

Volumn 35, Issue 2, 2010, Pages 115-121

  Dahele, Max ^a,b   Skinner, Matthew ^a   Schultz, Brenda ^a   Cardoso, Marlene ^a   Bell, Chris ^a   Ung, Yee C ^a,b  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adjuvant radiotherapy; Gastric cancer; Intensity modulated radiotherapy; TomoTherapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION FIELD; STOMACH CANCER; TOMOTHERAPY; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77952466994     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2009.03.003     Document Type: Article

References (42)

1. Canadian Cancer Statistics 2007. Available at: Last accessed August 5, 2007. http://www.cancer.ca/canada-wide/publications/publications%20on%20cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/English%20files%20heading/pdf%20not%20in%20publications%20section/2007%20Canadian%20Cancer%20Statistics%20%20PDF%20English_1816216925.ashx.
2. Yeoh K.G. How do we improve outcomes for gastric cancer?. J. Gastroenterol. Hepatol 2007, 22:970-972.
3. Foukakis T., Lundell L., Gubanski M., et al. Advances in the treatment of patients with gastric adenocarcinoma. Acta. Oncol 2007, 46:277-285.
4. Ng K., Meyerhardt J.A., Fuchs C.S. Adjuvant and neoadjuvant approaches in gastric cancer. Cancer. J 2007, 13:168-174.
5. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med 2001, 345:725-730.
6. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med 2006, 355:11-20.
7. Macdonald, J.S.; Smalley, S.; Benedetti, J.; et al. Postoperative combined radiation and chemotherapy improves disease free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup Study INT-0116 (SWOG 9008), Proceedings of the ASCO gastrointestinal cancers symposium 6; 2004.
8. Smalley S.R., Gunderson L., Tepper J., et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int. J. Radiat. Oncol. Biol. Phys 2002, 52:283-293.
9. Della Biancia C., Hunt M., Furhang E., et al. Radiation treatment planning techniques for lymphoma of the stomach. Int. J. Radiat. Oncol. Biol. Phys 2005, 62:745-751.
10. Leong T., Willis D., Joon D.L., et al. 3D conformal radiotherapy for gastric cancer--results of a comparative planning study. Radiother. Oncol 2005, 74:301-306.
11. Wieland P., Dobler B., Mai S., et al. IMRT for postoperative treatment of gastric cancer: Covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int. J. Radiat. Oncol. Biol. Phys 2004, 59:1236-1244.
12. Ringash J., Perkins G., Brierley J., et al. IMRT for adjuvant radiation in gastric cancer: A preferred plan?. Int. J. Radiat. Oncol. Biol. Phys 2005, 63:732-738.
13. Milano M.T., Garofalo M.C., Chmura S.J., et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: Early clinical outcome and dosimetric comparison with conventional techniques. Br. J. Radiol 2006, 79:497-503.
14. Welsh J.S., Patel R.R., Ritter M.A., et al. Helical tomotherapy: An innovative technology and approach to radiation therapy. Technol. Cancer. Res. Treat. 2002, 1:311-316.
15. Vanderstraeten B., Reynaert N., Paelinck L., et al. Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med. Phys 2006, 33:3149-3158.
16. Sheng K., Molloy J.A., Read P.W. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006, 65:917-923.
17. Sheng K., Molloy J.A., Larner J.M., et al. A dosimetric comparison of non-coplanar IMRT versus helical tomotherapy for nasal cavity and paranasal sinus cancer. Radiother. Oncol 2007, 82:174-178.
18. Pezner R.D., Liu A., Han C., et al. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother. Oncol 2006, 81:81-87.
19. Ten Haken R.K., Lawrence T.S. The clinical application of intensity-modulated radiation therapy. Semin. Radiat. Oncol 2006, 16:224-231.
20. Singh A.K., Tierney R.M., Low D.A., et al. A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: Implications for radiation dose escalation in carcinoma of the pancreas. Radiat. Oncol 2006, 1:33.
21. Byrne T., Ramsey C., Mahan S., et al. The dosimetric impact of respiration motion on 3D, IMRT, and tomotherapy treatment delivery. Int. J. Radiat. Oncol. Biol. Phys 2005, 63:2450.
22. Wysocka B.A., Kassam Z., Lockwood G., et al. Assessment of intra and interfractional organ motion during adjuvant radiochemotherapy in gastric cancer. J. Clin. Oncol 2007, 25:15132.
23. Gierga D.P., Chen G.T., Kung J.H., et al. Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions. Int. J. Radiat. Oncol. Biol. Phys 2004, 58:1584-1595.
24. Zhang T., Lu W., Olivera G.H., et al. Breathing-synchronized delivery: A potential four-dimensional tomotherapy treatment technique. Int. J. Radiat. Oncol. Biol. Phys 2007, 68:1572-1578.
25. Duan J., Shen S., Fiveash J.B., et al. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: A volumetric dose measurement study. Med. Phys 2006, 33:1380-1387.
26. Kanagaki B., Read P.W., Molloy J.A., et al. A motion phantom study on helical tomotherapy: The dosimetric impacts of delivery technique and motion. Phys. Med. Biol 2007, 52:243-255.
27. Thilmann C., Haring P., Thilmann L., et al. The influence of breathing motion on intensity modulated radiotherapy in the step-and-shoot technique: Phantom measurements for irradiation of superficial target volumes. Phys. Med. Biol. 2006, 51:117-126.
28. Craft D., Suss P., Bortfeld T., et al. The tradeoff between treatment plan quality and required number of monitor units in intensity-modulated radiotherapy. Int. J. Radiat. Oncol. Biol. Phys 2007, 67:1596-1605.
29. Seco J., Sharp G.C., Turcotte J., et al. Effects of organ motion on IMRT treatments with segments of few monitor units. Med. Phys 2007, 34:923-934.
30. Ehler E.D., Nelms B.E., Tome W.A. On the dose to a moving target while employing different IMRT delivery mechanisms. Radiother. Oncol 2007, 83:49-56.
31. Jiang S.B., Pope C., Al Jarrah K.M., et al. An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys. Med. Biol 2003, 48:1773-1784.
32. Li X.A., Qi X.S., Pitterle M., et al. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int. J. Radiat. Oncol. Biol. Phys 2007, 68:581-591.
33. Kassam Z., Lockwood G., O'Brien C., et al. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. Int. J. Radiat. Oncol. Biol. Phys 2006, 65:713-719.
34. O'Connell M.J., Mailliard J.A., Kahn M.J., et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J. Clin. Oncol 1997, 15:246-250.
35. Chau I., Norman A.R., Cunningham D., et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann. Oncol 2005, 16:549-557.
36. Kost S., Dorr W., Keinert K., et al. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int. J. Radiat. Biol 2002, 78:695-702.
37. Jansen E.P., Saunders M.P., Boot H., et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int. J. Radiat. Oncol. Biol. Phys 2007, 67:781-785.
38. Cassady J.R. Clinical radiation nephropathy. Int. J. Radiat. Oncol. Biol. Phys 1995, 31:1249-1256.
39. Wysocka B., Kassam Z., Lockwood G., et al. Late toxicity after adjuvant radiochemotherapy for gastric adenocarcinoma. J. Clin. Oncol 2006, 24:14042.
40. Macdonald J.S. Role of post-operative chemoradiation in resected gastric cancer. J. Surg. Oncol. 2005, 90:166-170.
41. Weiss E., Hess C.F. The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther. Onkol 2003, 179:21-30.
42. Mell L.K., Mehrotra A.K., Mundt A.J. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer 2005, 104:1296-1303.